Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
2/26/2020
FDA Catches Lies and Violations of Chinese Heparin Producer Yibin Liha...
2/26/2020
McKinsey Assesses Impacts of Covid-19 on China Healthcare
2/26/2020
Snapshot of 11 Biopharma Cos Seeking IPOs at Shanghai’s Star Board
2/26/2020
PhIRDA Advocates the Establishment of CEUA System for Drug Authorizati...
2/26/2020
China Issues New Policy to Strengthen Pharmacy Affairs and Drug Ration...
2/26/2020
Vir Biotech and WuXi Biologics Partners to Develop mAbs for Covid-19 T...
2/26/2020
MabPlex Launches Two New Cell Culture Production Lines
2/26/2020
US Initiates First Study of Gilead's Remdesivir for Coronavirus Treatm...
2/26/2020
Gilead's Antiviral Remdesivir Granted Three Patents in China
2/26/2020
APEIRON's Respiratory Drug to Start Pilot Trial for Covid-19 in China
2/25/2020
EPO and CNIPA Announce Pilot Programme to Enhance PCT Co-operation
2/25/2020
Gilead JV's NDA for CAR-T Cancer Therapy Accepted in China
2/25/2020
2019 Ends and 2020 Begins with a Flurry of Biosimilar Activity in East...
2/25/2020
Almirall and Paratek Enter into a License Agreement for Seysara in Chi...
2/25/2020
Ascentage Pharma Approved for Phase Ib/II Trial of IAP Inhibitor APG-1...
2/25/2020
Medivir and SJZ Yuanmai Biotech Enter Licensing Pact for Herpes Drug X...
2/24/2020
Sanofi to Compete in API Sector against China and India with New Compa...
2/24/2020
GSK Ties Up with China's Clover Biopharma in Coronavirus Vaccine Devel...
2/24/2020
China Issues New Policy to Reduce Urban Employee BMI Premium Contribut...
2/24/2020
China Begins Animal Testing of First Novel Coronavirus Vaccines
2/24/2020
Wuxi Vaccines Inks $3B Manufacturing Deal with 'Global Vaccine Leader'
2/21/2020
Recent Executive Moves
2/21/2020
WHO: Early Trial Results for Coronavirus Treatments Expected in 3 week...
2/21/2020
Chinese Foundation Grants $2.1M to Columbia Researchers to Find Antivi...
2/20/2020
Wuxi AppTec Eyes U.S. Expansion amid Chinese Facilities Disruptions
2/20/2020
Jinghua Pharma Drops Development of Two mAbs Licensed from Kadmon
2/20/2020
Vifor Pharma and Fresenius Kabi Create JV in China for IV Iron Portfol...
2/20/2020
Pharma and MedTech Outlook Clouded by Coronavirus Outbreak
2/20/2020
Teva Pharm Eyes Launch of Huntington's Drug in China This year
2/20/2020
U.S. FDA Suspends China Inspections, Warns of Potential Shortages
Page:
192
/
719
Total number of articles:
21568
:
[First]
[<<]
[190]
[191]
[192]
[193]
[194]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Commentaries
Expert Opinions
Interviews
Case Studies
Company Profiles
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit